Skip to main navigation Skip to search Skip to main content

Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection

  • Mark A. Marzinke
  • , William Clarke
  • , Lei Wang
  • , Vanessa Cummings
  • , Ting Yuan Liu
  • , Estelle Piwowar-Manning
  • , Autumn Breaud
  • , Sam Griffith
  • , Susan Buchbinder
  • , Steven Shoptaw
  • , Carlos Del Rio
  • , Manya Magnus
  • , Sharon Mannheimer
  • , Sheldon D. Fields
  • , Kenneth H. Mayer
  • , Darrell P. Wheeler
  • , Beryl A. Koblin
  • , Susan H. Eshleman
  • , Jessica M. Fogel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nondisclosure of HIV status in a clinical trial setting: Antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Neuroscience